Endo International Ordinary Shares reported $141.64M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Aerie Pharmaceuticals AERI:US $ 7.12M 0.22M
Amarin AMRN:US $ 0.03M 0.02M
Ani Pharmaceuticals ANIP:US $ 2.53M 77K
Antares Pharma ATRS:US $ 1.14M 0.17M
Bristol Myers Squibb BMY:US $ 330M 23M
Coherus Biosciences CHRS:US $ 5.75M 0.1M
Eli Lilly And LLY:US $ 86.9M 0.9M
Endo International Ordinary Shares ENDP:US $ 141.64M 6.95M
Flexion Therapeutics FLXN:US $ 5.18M 9K
JAZZ PHA JAZZ:US $ 69.82M 41.24M
Lannett LCI:US $ 13.22M 0.59M
Novartis NOVN:VX 201M 1000K
Pacira Pharmaceuticals PCRX:US $ 7.02M 0.05M
Patterson Companies PDCO:US $ 5.2M 0.48M
Pfizer PFE:US $ 316M 20M
Phibro Animal Health PAHC:US $ 3.03M 0.05M
Revance Therapeutics RVNC:US $ 1.57M 9K
Supernus Pharmaceuticals SUPN:US $ 5.47M 0.4M
Teva Pharmaceutical TEVA:IT 240M 1000K
Xeris Pharmaceuticals Inc XERS:US $ 1.8M 4K
Zoetis ZTS:US $ 57M 0M